CSN1S1 and idiopathic pulmonary fibrosis: The results of this study provide evidence supporting use of the CASA-Q cough domain and UCSD-SOBQ in clinical trials for patients with IPF (Fabbri et al., 2009; Meek & Lareau, 2003; Verrill, Barton, Beasley, & Lippard, 2005).